N.F.U. Mutual Unit Managers Ltd’s Edwards Lifesciences EW Stock Holding History

N.F.U. Mutual Unit Managers Ltd’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.65M	Buy	+19,080	New	+$1.7M	0.3%	92

Other funds holding EW

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

N.F.U. Mutual Unit Managers Ltd's EW Position: Q3 2026 in Review

N.F.U. Mutual Unit Managers Ltd opened a new position in Edwards Lifesciences (EW) in Q3 2026: 19,080 shares worth $1.65M. The stake represents 0.3% of the portfolio and ranks #92 among its holdings.

1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

N.F.U. Mutual Unit Managers Ltd held 19,080 shares of Edwards Lifesciences worth $1.65M as of Q3 2026.
Edwards Lifesciences was a new N.F.U. Mutual Unit Managers Ltd position in Q3 2026.
Edwards Lifesciences made up 0.3% of N.F.U. Mutual Unit Managers Ltd's portfolio in Q3 2026, its #92 holding.
1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on N.F.U. Mutual Unit Managers Ltd's 13F filing for Q3 2026, filed 12 Nov 2026.